Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Photoman77on Sep 13, 2021 1:25pm
192 Views
Post# 33849176

Grail test is a POS

Grail test is a POShttps://news.harvard.edu/gazette/story/2020/03/in-clinical-study-blood-test-can-detect-range-of-cancers/ 

"In a study involving thousands of participants, a new blood test (Grail) detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute, a Harvard affiliate, and the Mayo Clinic."

Here is the problem ^^


39 percent sensitivity for patients with stage I cancer
69 percent sensitivity for those with stage II cancer
83 percent sensitivity for those with stage III cancer
92 percent sensitivity for those with stage IV cacner

39% stage 1 is terrible for Grail! That's worse that a grade F in school.

Aristotle is far superior with over 90% accuracy at this stage for most common cancers

Grail for 8 billion dolalrs lol!



<< Previous
Bullboard Posts
Next >>